🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the makers of acetaminophen, alleging the corporations hid potential risks that the pain reliever created to children's neurological development.

This legal action follows thirty days after Former President Trump publicized an unsubstantiated connection between taking acetaminophen - referred to as paracetamol - while pregnant and autism in children.

Paxton is filing suit against Johnson & Johnson, which previously sold the medication, the sole analgesic recommended for pregnant women, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "deceived the public by profiting off of suffering and marketing drugs regardless of the risks."

The company states there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, intentionally threatening numerous people to increase profits," Paxton, a Republican, said.

The manufacturer said in a statement that it was "very worried by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the health of American women and children."

On its official site, Kenvue also said it had "regularly reviewed the applicable studies and there is lacking reliable evidence that indicates a proven link between consuming acetaminophen and autism spectrum disorder."

Groups speaking for medical professionals and medical practitioners concur.

ACOG has said acetaminophen - the primary component in acetaminophen - is a restricted selection for pregnant women to treat pain and elevated temperature, which can create significant medical dangers if left untreated.

"In more than two decades of research on the consumption of paracetamol in pregnancy, not a single reputable study has definitively established that the usage of acetaminophen in any trimester of pregnancy leads to neurodevelopmental disorders in offspring," the association stated.

The court filing references current declarations from the Trump administration in asserting the medication is potentially dangerous.

In recent weeks, Trump caused concern from public health officials when he told women during pregnancy to "fight like hell" not to take acetaminophen when sick.

The US Food and Drug Administration then published an announcement that medical professionals should consider limiting the consumption of acetaminophen, while also declaring that "a proven link" between the medication and autism spectrum disorder in young ones has remains unverified.

Health Secretary Kennedy, who oversees the FDA, had pledged in April to conduct "extensive scientific investigation" that would identify the cause of autism spectrum disorder in a short period.

But authorities warned that identifying a unique factor of autism spectrum disorder - considered by experts to be the consequence of a complicated interplay of inherited and external influences - would prove challenging.

Autism spectrum disorder is a form of enduring cognitive variation and impairment that impacts how people experience and engage with the surroundings, and is diagnosed using medical professional evaluations.

In his court filing, Paxton - who supports Trump who is campaigning for federal office - alleges Kenvue and J&J "willfully ignored and attempted to silence the science" around acetaminophen and autism spectrum disorder.

This legal action aims to force the corporations "remove any commercial messaging" that states Tylenol is secure for women during pregnancy.

The Texas lawsuit echoes the complaints of a collection of mothers and fathers of minors with autism spectrum disorder and ADHD who took legal action against the manufacturers of acetaminophen in recently.

Judicial authorities dismissed the legal action, declaring investigations from the parents' expert witnesses was not conclusive.